SAGA Diagnostics

SAGA Diagnostics develops ultrasensitive liquid biopsy tests for early detection of cancer relapse and personalized cancer treatment. The tests are based on the company’s proprietary technologies for analyzing circulating tumor DNA (ctDNA).

sagadiagnostics.com
LinkedIn

Press release:
The Sciety syndicate and Segulah Medical Acceleration invest MSEK 106 in SAGA Diagnostics